NCT02812680View on ClinicalTrials.gov

The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Esophageal Cancer
Interventions
OTHER

Blood Draw

Blood draw to assess the use of circulating microRNA (miRNA) and circulating tumour cells (CTC) as biomarkers of cancer and predictive markers for neoadjuvant therapy.

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02812680 - The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma | Biotech Hunter | Biotech Hunter